Home > Our Indexes > LSCIBC

Download Methodology

LifeSci Biotechnology Clinical Trials Index

The LifeSci Biotechnology Clinical Trials Index ("LSCIBC") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The inception date for LSCIBC was November 3, 2014.

Prior Day Closing Value4275.51
Prior Day Change %-2.07%
Current Day Change %+0.60%

Top 10 Constituents (Dec 15, 2017)

Constituent Ticker Weight
Anaptysbio Inc ANAB 4.47%
Myokardia Inc MYOK 3.06%
Dynavax Technologies Corp DVAX 2.76%
Beigene Ltd-adr BGNE 2.65%
Arena Pharmaceuticals Inc ARNA 2.52%
Sangamo Therapeutics Inc SGMO 2.45%
Sage Therapeutics Inc SAGE 2.34%
Blueprint Medicines Corp BPMC 2.18%
Juno Therapeutics Inc JUNO 2.17%
Insmed Inc INSM 2.15%
Data Updated Daily
Download All Constituents